Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEpe Special Opp Regulatory News (ESO)

Share Price Information for Epe Special Opp (ESO)

Share Price is delayed by 15 minutes
Get Live Data
237.00    -1.00 (-0.42%)
Bid:
232.00
Ask:
242.00
Spread: 10.00 (4.31%)
Market Cap: £58.41m
ESO Live PriceLast checked at - London Stock Exchange

Intraday Epe Special Opp Share Chart

Investment

4 Jul 2025 10:00

RNS Number : 8005P
EPE Special Opportunities Limited
04 July 2025
 

EPE Special Opportunities Limited

 

Investment

 

 

EPE Special Opportunities Limited ("ESO" or the "Company") is pleased to announce that on 2 July 2025, ESO Investments 1 Limited (an undertaking of ESO, in which it is the sole investor) ("ESO 1") acquired a majority stake in Prism Holdco (2025) Limited (the "Target" or, together with undertakings, the "Target Group") (the "Transaction").

 

The Target Group owns the LSA International brand which designs, develops and distributes a wide range of award-winning interior products, including glassware, tableware and interior accessories. The Target Group has achieved a strong reputation for design led, contemporary products centred on quality, craftmanship and sustainability. The Target Group supplies a broad range of premium retailers, hospitality partners and distributors in the UK and international markets, as well as operating e-commerce and marketplace channels. ESO will assist the Target Group's future growth ambitions, accelerated by collaboration and integration with the Company's existing portfolio company in the sector, the Rayware Group.

 

As part of the transaction, ESO 1 is investing up to £2.1 million (funded by cash reserves advanced from ESO) to fund the paydown of bank debt (£1.1 million) and to support working capital (£1.0 million), and ESO issued 298,013 shares to the former shareholders of LSA International. Following the Transaction, ESO has available cash of £7.1 million. The Transaction has no impact on the Company's net asset value.

 

Application has been made for the admission to trading on AIM of the 298,013 consideration shares which is expected to occur on 9 July 2025. Following admission, ESO will have 28,396,073 ordinary shares in issue with each ordinary share carrying the right to one vote. The total number of voting rights in the Company is therefore 28,396,073. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interests in, the Company under the FCA's Disclosure and Transparency Rules.

 

About ESO

 

· ESO is an AIM-quoted, private equity investment company, whose objective is to provide long-term return on equity for its shareholders by investing in SMEs.

 

· ESO seeks to invest up to £30 million into companies with strong fundamentals, including defensible competitive positioning and high levels of cash generation, and aims to partner with outstanding management teams to combine operational and financial expertise in each investment.

 

· ESO will consider most industry sectors, including consumer, retail, manufacturing, financial services and the broader services sectors, and can make direct investments, special situations investments, primary and secondary fund investments and private investments in public equities.

 

· ESO's investment horizon is flexible, creating the opportunity to maximise value via optimising exit timing, compounding returns and re-investing behind successful management teams.

 

The person responsible for releasing this information on behalf of the Company is Amanda Robinson of Langham Hall Fund Management (Jersey) Limited.

 

Enquiries:

 

EPIC Investment Partners LLP

+44 (0) 207 269 8860

Rupert Palmer

Langham Hall Fund Management (Jersey) Limited

+44 (0) 153 488 5200

Amanda Robinson

 

Cardew Group Limited

+44 (0) 207 930 0777

Richard Spiegelberg

 

Deutsche Numis

+44 (0) 207 260 1000

Nominated Advisor:

Stuart Skinner / Emma Brown

Corporate Broker:

Charles Farquhar

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQRIMPTMTIMMFA
Date   Source Headline
23rd Dec 20247:00 amRNSTransaction in Own Shares
20th Dec 20245:00 pmRNSTransaction in Own Shares
19th Dec 20247:00 amRNSTransaction in Own Shares
18th Dec 20241:00 pmRNSTransaction in Own Shares
13th Dec 20247:00 amRNSNet Asset Value(s)
11th Dec 20247:10 amRNSVesting - Share Matching Scheme/PDMR Shareholdings
11th Dec 20247:00 amRNSTransaction in Own Shares
10th Dec 20247:00 amRNSTransaction in Own Shares
6th Dec 20247:00 amRNSAnnouncement of Share Buy Backs
3rd Dec 20247:10 amRNSUpdate on ZDP Share Buybacks
3rd Dec 20247:00 amRNSTransaction in Own Shares
22nd Nov 20241:00 pmRNSTransaction in Own Shares
22nd Nov 20247:10 amRNSUpdate on Share Buy Backs
22nd Nov 20247:00 amRNSTransaction in Own Shares
20th Nov 20241:00 pmRNSTransaction in Own Shares
18th Nov 20247:00 amRNSTransaction in Own Shares
14th Nov 20247:00 amRNSTransaction in Own Shares
13th Nov 202411:00 amRNSTransaction in Own Shares
12th Nov 20246:29 pmRNSTransaction in Own Shares
12th Nov 20247:00 amRNSNet Asset Value(s)
11th Nov 20246:01 pmRNSHolding(s) in Company
11th Nov 20246:00 pmRNSTransaction in Own Shares
6th Nov 202410:30 amRNSTransaction in Own Shares
4th Nov 20246:30 pmRNSTransaction in Own Shares
1st Nov 20247:00 amRNSAnnouncement of ZDP Share Buybacks
31st Oct 202411:00 amRNSTransaction in Own Shares
29th Oct 202410:00 amRNSTransaction in Own Shares
29th Oct 20247:00 amRNSDirector/PDMR Shareholding
28th Oct 20249:00 amRNSTransaction in Own Shares
18th Oct 20247:00 amRNSAppointment of Non-Executive Director
15th Oct 20245:00 pmRNSTransaction in Own Shares
11th Oct 20245:00 pmRNSTransaction in Own Shares
10th Oct 20247:00 amRNSNet Asset Value(s)
9th Oct 202410:30 amRNSTransaction in Own Shares
8th Oct 20247:00 amRNSAnnouncement of Share Buy Backs
2nd Oct 202411:15 amRNSPortfolio Update
20th Sep 20247:00 amRNSHolding(s) in Company
13th Sep 20247:00 amRNSNet Asset Value(s)
10th Sep 20247:00 amRNSHalf-year Report
26th Jul 20247:00 amRNSInterest Payment on Unsecured Loan Notes
18th Jul 20247:00 amRNSAmendment and Extension of Unsecured Loan Notes
11th Jul 20247:00 amRNSNet Asset Value(s)
18th Jun 20247:00 amRNSNet Asset Value(s)
14th Jun 20245:00 pmRNSResult of AGM
16th May 20247:00 amRNSNotice of AGM
13th May 20247:00 amRNSNet Asset Value(s)
30th Apr 20247:00 amRNSDirector/PDMR Shareholding
16th Apr 20247:00 amRNSNet Asset Value(s)
9th Apr 20247:00 amRNSVesting - Share Matching Scheme/PDMR Shareholdings
9th Apr 20247:00 amRNSPosting of Report & Accounts

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.